About Acetylserotonin O-methyltransferase
Acetylserotonin O-methyltransferase (ASMT) is a protein
from Homo sapiens identified by UniProt accession
P46597, 345 residues long.
MolForge cross-references it against 0 known binders and
58 disease associations.
Target properties
| Protein name | Acetylserotonin O-methyltransferase |
| UniProt accession | P46597 |
| Gene | ASMT |
| Organism | Homo sapiens |
| Length | 345 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (58)
Diseases linked to this target (Open Targets).
- lung adenocarcinoma · score 0.21
- cutaneous melanoma · score 0.16
- triple-negative breast cancer · score 0.06
- X-linked intellectual disability-macrocephaly-macroorchidism syndrome · score 0.04
- hepatocellular carcinoma · score 0.04
- Testicular regression syndrome · score 0.04
- X-linked non-syndromic intellectual disability · score 0.04
- 46,XX testicular disorder of sex development · score 0.04
- male infertility with azoospermia or oligozoospermia due to single gene mutation · score 0.04
- familial male-limited precocious puberty · score 0.04
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P46597-F1 | alphafold | PREDICTED | 95.52 | — |
Amino-acid sequence (345 residues)
MGSSEDQAYR LLNDYANGFM VSQVLFAACE LGVFDLLAEA PGPLDVAAVA AGVRASAHGT ELLLDICVSL KLLKVETRGG KAFYRNTELS SDYLTTVSPT SQCSMLKYMG RTSYRCWGHL ADAVREGRNQ YLETFGVPAE ELFTAIYRSE GERLQFMQAL QEVWSVNGRS VLTAFDLSVF PLMCDLGGGA GALAKECMSL YPGCKITVFD IPEVVWTAKQ HFSFQEEEQI DFQEGDFFKD PLPEADLYIL ARVLHDWADG KCSHLLERIY HTCKPGGGIL VIESLLDEDR RGPLLTQLYS LNMLVQTEGQ ERTPTHYHML LSSAGFRDFQ FKKTGAIYDA ILARK
Explore Acetylserotonin O-methyltransferase with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets